誉衡药业拟回购注销216万股限制性股票 涉及3名离职激励对象

Group 1 - The company Harbin Yuheng Pharmaceutical Co., Ltd. plans to repurchase and cancel 2.16 million restricted shares granted to three former incentive recipients who no longer meet the incentive conditions due to termination of their labor relations [1] - The repurchase will be conducted at the grant price plus the interest from the People's Bank of China for the same period, in accordance with relevant regulations [1] - The Compensation and Assessment Committee confirmed that the repurchase complies with the Shenzhen Stock Exchange listing rules and will not harm the interests of the company or its shareholders [1] Group 2 - Following the completion of the repurchase, the company will reduce its registered capital and proceed with the necessary procedures for share repurchase cancellation and business registration changes [1] - The company stated that this matter will not impact its ongoing development or have a substantial adverse effect on its financial status and operating results [1]